Dexamethasone Implant in Patients with Diabetic Macular Edema Resistant to Anti-VEGF Therapy
Author(s) -
Serhad Nalçacı,
Cezmi Akkın,
Filiz Afrashı
Publication year - 2019
Publication title -
turkish journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.654
H-Index - 10
eISSN - 2147-2661
pISSN - 1300-0659
DOI - 10.4274/tjo.galenos.2018.84665
Subject(s) - medicine , dexamethasone , implant , ophthalmology , ranibizumab , visual acuity , intraocular pressure , macular edema , diabetic retinopathy , diabetic macular edema , endophthalmitis , surgery , bevacizumab , chemotherapy , diabetes mellitus , endocrinology
To investigate the efficacy of single dose intravitreal dexamethasone implant in patients with diabetic macular edema (DME) resistant to anti-VEGF therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom